Flagship Pioneering trades 9,263 Moderna (MRNA) shares via option exercise - Stock Titan
📅 On May 21, 2026, Flagship Pioneering exercised options for 9,263 Moderna shares at $19.15 per share.
💰 The same entity immediately sold those 9,263 shares on the open market at an average price of $46.84 per share.
👤 Noubar Afeyan is the ultimate control person of the reporting entities and holds over 2 million direct shares.
🏦 Related Flagship Ventures funds hold additional indirect stakes totaling approximately 4.6 million shares combined.
📉 The transaction resulted in a net profit per share of roughly $27.69 before fees due to the spread between exercise and sale prices.
⚖️ Afeyan disclaims full beneficial ownership of Flagship entity holdings, retaining interest only to the extent of his pecuniary stake.
Bullish Signals
- The insider sold shares at a significant premium to the option strike price ($46.84 vs $19.15), suggesting confidence in the stock's value relative to the cost basis.
- Noubar Afeyan maintains substantial direct ownership of over 2.2 million shares, indicating continued skin in the game despite the sale activity.
- The matched exercise-and-sell transaction is a neutral liquidity event rather than a signal of distress or lack of conviction.
Risk Factors
- The open-market sale of 9,263 shares increases immediate supply, which can exert short-term downward pressure on the stock price.
- Afeyan's disclaimer of beneficial ownership for Flagship entity holdings limits transparency regarding his total economic exposure to the company.
Full Analysis
On May 21, 2026, Flagship Pioneering, LLC executed a matched exercise-and-sell transaction involving Moderna (MRNA) shares. The entity exercised stock options to acquire 9,263 shares at an exercise price of $19.15 per share. Immediately following the acquisition, Flagship Pioneering sold the exact same quantity of shares on the open market at an average price of $46.84 per share.
The transaction was conducted by entities associated with Moderna director Noubar Afeyan. Following the sale, Flagship Pioneering retained a small indirect holding of 3,924 shares. The filing details significant direct and indirect holdings held by Noubar Afeyan and related Flagship Ventures funds, totaling millions of shares, while noting that Afeyan disclaims full beneficial ownership of shares held by the Flagship entities except to the extent of his pecuniary interest.
This Form 4 filing reports a standard exercise-and-sell sequence where an insider entity converts vested options into cash by selling the underlying stock. The sale price of $46.84 represents a substantial premium over the $19.15 option strike price, indicating the shares were purchased at a discount relative to their market value at the time of the transaction.
